[Long-term therapy of liver diseases].
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002779:Cholestasis / Q000188:drug therapy; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008107:Liver Diseases / Q000188:drug therapy*; D011379:Prognosis
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D002792:Cholestyramine Resin; D003520:Cyclophosphamide; D001379:Azathioprine
Zur Problematik der Langzeittherapie von Leberekrankungen.